GlassScriptPhysician profile
Carlos Ortiz
NPI 1457702482
$4,705.52
in general payments reported to CMS, 2019-2025
29 companies · $528 in 2025
The $528 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $625 · 2023: $2,203 · 2024: $1,349 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,958 · Travel and Lodging: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,958.17 |
| Travel and Lodging | $1,122.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,477.01 | 2022-2023 | Venaseal |
| Cvrx, INC. | $979.73 | 2022-2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $403.52 | 2022-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $311.22 | 2022-2024 | Verquvo |
| Novartis Pharmaceuticals Corporation | $248.83 | 2022-2025 | |
| Kestra Medical Technology Services, INC. | $205.26 | 2024-2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $180.73 | 2022-2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $113.04 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.26 | 2024-2025 | Lifevest |
| Boston Scientific Corporation | $80.70 | 2023-2024 | Baylis Medical Company Radiofrequency Puncture Generator, Watchman Access System |
| Imperative Care, INC | $68.98 | 2024 | Symphony Catheter, Prodigy Catheter |
| Pfizer INC. | $62.62 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $59.21 | 2023-2025 | Camzyos, Eliquis |
| Scpharmaceuticals INC. | $48.05 | 2024-2025 | |
| Amgen INC. | $44.60 | 2024-2025 | Repatha, Repatha |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $44.57 | 2025 | Amplatzer Amulet |
| Abiomed | $39.11 | 2024 | Impella |
| Novo Nordisk INC | $32.20 | 2022-2023 | Ozempic |
| United Therapeutics Corporation | $25.55 | 2024 | Tyvaso |
| Teleflex LLC | $24.17 | 2024 | Manta |
| Kiniksa Pharmaceuticals International, Plc | $23.55 | 2024 | Arcalyst |
| Atricure, INC. | $22.58 | 2025 | Synergy Ablation System |
| Astrazeneca Pharmaceuticals LP | $22.05 | 2025 | Farxiga |
| Lexicon Pharmaceuticals, INC. | $20.37 | 2023 | Inpefa |
| Irhythm Technologies, INC. | $18.92 | 2024 | Zio Monitor, Zio Xt Patch |
| Bard Peripheral Vascular, INC. | $17.41 | 2024 | Crosser Iq |
| Vivaquant INC, Dba Rhythm Express | $16.80 | 2024 | Rhythm Express |
| Jubilant Draximage INC. | $15.48 | 2024 | Technetium Tc 99m Sestamibi |
| Bardy Diagnostics, INC. | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Ortiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.